BeOne Medicines Ltd. cotiza a 354.47 USD y tiene una capitalización bursátil de $40.3B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of vari…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $2.05 | $1.96 | $0.58 |
| Estimado | $1.88 | $1.63 | $0.81 | $1.30 |
| Sorpresa | — | +25.8% | +142.0% | -55.4% |
| Métrica | ONC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 87.5% | 57.0% | +30.4% |
| Operating Margin | 8.4% | -38.6% | +47.0% |
| Net Margin | 5.4% | -33.6% | +38.9% |
| FCF Margin | 17.6% | -13.9% | +31.5% |
| ROE | 6.6% | -40.4% | +47.0% |
| ROA | 3.5% | -32.0% | +35.5% |
| Current Ratio | 3.41 | 2.84 | +0.57 |
| Debt / Equity | 0.19 | 0.28 | -0.09 |